FMCAX | VIMSX | FMCAX / VIMSX | |
Total Expense Ratio | 1.17 | 0.17 | 688% |
Annual Report Gross Expense Ratio | 1.17 | 0.17 | 688% |
Fund Existence | 29 years | 27 years | - |
Gain YTD | -0.919 | 2.751 | -33% |
Front Load | 4% | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.2B | 185B | 1% |
Annual Yield % from dividends | 0.07 | 1.40 | 5% |
Returns for 1 year | 3.39 | 11.58 | 29% |
Returns for 3 years | 20.03 | 39.11 | 51% |
Returns for 5 years | 39.67 | 69.57 | 57% |
Returns for 10 years | 24.93 | 114.00 | 22% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GGGPX | 40.40 | -0.53 | -1.29% |
Goldman Sachs Large Cap Equity P | |||
SGQIX | 43.87 | -0.75 | -1.68% |
DWS International Growth Inst | |||
AIBBX | 14.52 | -0.25 | -1.69% |
Aristotle Small Cap Equity I-2 | |||
WMGYX | 26.54 | -0.54 | -1.99% |
Macquarie Mid Cap Growth Y | |||
PHPSX | 18.77 | -0.39 | -2.04% |
ProFunds Pharmaceuticals UltraSector Svc |